These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 12627256

  • 1. [Death inducing ligands in combination with ionizing radiation: objective and current knowledge].
    Belka C, Betsch A, Marini P, Jendrossek V, Bamberg M, Budach W.
    Strahlenther Onkol; 2003 Mar; 179(3):141-51. PubMed ID: 12627256
    [Abstract] [Full Text] [Related]

  • 2. Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis.
    Marini P, Schmid A, Jendrossek V, Faltin H, Daniel PT, Budach W, Belka C.
    BMC Cancer; 2005 Jan 14; 5():5. PubMed ID: 15651986
    [Abstract] [Full Text] [Related]

  • 3. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL.
    Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H, Bamberg M, Schulze-Osthoff K, Budach W.
    Oncogene; 2001 Apr 19; 20(17):2190-6. PubMed ID: 11360204
    [Abstract] [Full Text] [Related]

  • 4. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S, Singh TR, Srivastava RK.
    Prostate; 2004 Sep 15; 61(1):35-49. PubMed ID: 15287092
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TRAIL and apoptosis induction by TNF-family death receptors.
    Wang S, El-Deiry WS.
    Oncogene; 2003 Nov 24; 22(53):8628-33. PubMed ID: 14634624
    [Abstract] [Full Text] [Related]

  • 7. Targeting death-receptors in radiation therapy.
    Niemöller O, Belka C.
    Results Probl Cell Differ; 2009 Nov 24; 49():219-39. PubMed ID: 19582410
    [Abstract] [Full Text] [Related]

  • 8. Potential and caveats of TRAIL in cancer therapy.
    Held J, Schulze-Osthoff K.
    Drug Resist Updat; 2001 Aug 24; 4(4):243-52. PubMed ID: 11991679
    [Abstract] [Full Text] [Related]

  • 9. The sequential treatment with ionizing radiation followed by TRAIL/Apo-2L reduces tumor growth and induces apoptosis of breast tumor xenografts in nude mice.
    Shankar S, Singh TR, Chen X, Thakkar H, Firnin J, Srivastava RK.
    Int J Oncol; 2004 May 24; 24(5):1133-40. PubMed ID: 15067334
    [Abstract] [Full Text] [Related]

  • 10. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells.
    Baierlein SA, Distel L, Sieber R, Weiss C, Rödel C, Sauer R, Rödel F.
    Strahlenther Onkol; 2006 Aug 24; 182(8):467-72. PubMed ID: 16896593
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents.
    Rowinsky EK.
    J Clin Oncol; 2005 Dec 20; 23(36):9394-407. PubMed ID: 16361639
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T, Suzuki H, Nagai S, Yamamoto K, Imakiire A, Takada E, Itoh M, Mizuguchi J.
    J Orthop Res; 2003 Sep 20; 21(5):949-57. PubMed ID: 12919886
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Sep 20; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 18. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 19. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M.
    Clin Cancer Res; 2004 Dec 01; 10(23):7884-95. PubMed ID: 15585621
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L, Fang B.
    Cancer Gene Ther; 2005 Mar 01; 12(3):228-37. PubMed ID: 15550937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.